Difficulty: Medium
Average Score: 80%
Practice
Which of the following antienzymes is a cholinesterase inhibitor?
Correct answer
A
Rationale
The correct answer is A) Physostigmine.
Physostigmine is a cholinesterase inhibitor, specifically an acetylcholinesterase inhibitor. It works by preventing the breakdown of acetylcholine in the synaptic cleft, leading to increased acetylcholine levels and enhanced cholinergic activity.
Option B) Selegiline is a monoamine oxidase inhibitor used in the treatment of Parkinson's disease and depression, not a cholinesterase inhibitor.
Option C) Aminocaproic acid is an antifibrinolytic agent used to prevent excessive bleeding, not a cholinesterase inhibitor.
Option D) Disulfiram is used in the treatment of alcohol dependence by causing an unpleasant reaction if alcohol is consumed, but it is not a cholinesterase inhibitor.
Understanding the mechanism of action of different medications is crucial in pharmacology to ensure safe and effective use. In the context of safety pharmacology across the lifespan, knowing the specific actions of drugs on various physiological systems is essential to prevent adverse effects, especially in vulnerable populations such as children and the elderly who may be more sensitive to medication effects. Physostigmine, as a cholinesterase inhibitor, has implications for conditions like myasthenia gravis and certain types of poisoning, making its correct identification important in clinical practice.
Physostigmine is a cholinesterase inhibitor, specifically an acetylcholinesterase inhibitor. It works by preventing the breakdown of acetylcholine in the synaptic cleft, leading to increased acetylcholine levels and enhanced cholinergic activity.
Option B) Selegiline is a monoamine oxidase inhibitor used in the treatment of Parkinson's disease and depression, not a cholinesterase inhibitor.
Option C) Aminocaproic acid is an antifibrinolytic agent used to prevent excessive bleeding, not a cholinesterase inhibitor.
Option D) Disulfiram is used in the treatment of alcohol dependence by causing an unpleasant reaction if alcohol is consumed, but it is not a cholinesterase inhibitor.
Understanding the mechanism of action of different medications is crucial in pharmacology to ensure safe and effective use. In the context of safety pharmacology across the lifespan, knowing the specific actions of drugs on various physiological systems is essential to prevent adverse effects, especially in vulnerable populations such as children and the elderly who may be more sensitive to medication effects. Physostigmine, as a cholinesterase inhibitor, has implications for conditions like myasthenia gravis and certain types of poisoning, making its correct identification important in clinical practice.